Insider Trading Activity For ResMed Inc. (NYSE:RMD)
Brett Sandercock , CFO of ResMed Inc. (NYSE:RMD) reportedly Sold 3,000 shares of the company’s stock at an average price of 103 for a total transaction amount of $309,000.00 SEC Form
Insider Trading History For ResMed Inc. (NYSE:RMD)
Analyst Ratings History For ResMed Inc. (NYSE:RMD)
- On 8/2/2017 Bank of America Downgraded rating Buy to Neutral
- On 10/12/2017 Jefferies Financial Group Reiterated Rating Sell with a price target of $56.00
- On 10/27/2017 Barclays Boost Price Target of rating Underweight with a price target of $68.00 to $70.00
- On 1/23/2018 Macquarie Downgraded rating Neutral to Sell
- On 1/23/2018 Northland Securities Upgraded rating Under Perform to Market Perform
- On 3/7/2018 Needham & Company LLC Reiterated Rating Hold
- On 4/4/2018 Citigroup Downgraded rating Buy to Neutral
Dividend Information For ResMed Inc. (NYSE:RMD)
ResMed Inc. (NYSE:RMD) pays an annual dividend of $1.48 with a yield of 1.46% and an average dividend growth of 7.50% (3 Year Average).
Dividend History For ResMed Inc. (NYSE:RMD)
Recent Trading Activity for ResMed Inc. (NYSE:RMD)
Shares of ResMed Inc. closed the previous trading session at 101.23 −1.88 1.82% with 103.61 shares trading hands.